April 22 (UPI) -- Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years.

The investment will create more than 12,000 jobs, Roche said — 1,000 with the company, and the remainder to support new U.S.

Chinese investment in the UK’s leading companies has surged to almost £90bn amid fears that Beijing is buying up Britain.

China warns president to ‘stop whining’ over tariffs after US curbs Nvidia chip sales in trade war - It comes as President ...

In addition, Pfizer Inc is set to open its first Beijing-based entity, a research center, to align clinical trials with ...

AstraZeneca unit sued over alleged monopoly ... CEOs on Friday to protect global industry and supply chains, as Beijing seeks to assuage foreign firms' concerns over the Chinese economy's health ...

In Q4 2024, AstraZeneca PLC (NASDAQ:AZN) was included in 14 billionaire portfolios with a total of $2.20 billion in combined ...

Investigators are examining medicines and active ingredients to determine whether production can be boosted domestically.

Biopharmaceutical giant AstraZeneca signed a landmark agreement to invest $2.5 billion in Beijing over the next five years.

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Donald Trump has vowed to hit imports of pharmaceuticals with new tariffs in a major setback for one of Britain’s largest ...